Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 10 04:00PM ET
48.68
Dollar change
-1.16
Percentage change
-2.33
%
Index- P/E- EPS (ttm)-2.82 Insider Own4.29% Shs Outstand85.34M Perf Week-5.00%
Market Cap4.16B Forward P/E- EPS next Y-5.01 Insider Trans-1.45% Shs Float81.69M Perf Month-5.70%
Income-239.59M PEG- EPS next Q-1.22 Inst Own67.59% Short Float22.22% Perf Quarter7.13%
Sales202.83M P/S20.49 EPS this Y-165.41% Inst Trans6.61% Short Ratio12.71 Perf Half Y-21.87%
Book/sh22.73 P/B2.14 EPS next Y2.66% ROA-11.03% Short Interest18.15M Perf Year-24.57%
Cash/sh22.68 P/C2.15 EPS next 5Y-3.70% ROE-13.07% 52W Range43.42 - 91.10 Perf YTD-22.24%
Dividend Est.- P/FCF- EPS past 5Y10.83% ROI-11.14% 52W High-46.56% Beta1.63
Dividend TTM- Quick Ratio21.64 Sales past 5Y33402.13% Gross Margin26.23% 52W Low12.11% ATR (14)2.59
Dividend Ex-Date- Current Ratio21.64 EPS Y/Y TTM37.49% Oper. Margin-163.88% RSI (14)47.42 Volatility5.26% 5.25%
Employees407 Debt/Eq0.12 Sales Y/Y TTM19.31% Profit Margin-118.13% Recom2.17 Target Price79.75
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q28.60% Payout- Rel Volume1.17 Prev Close49.84
Sales Surprise-90.83% EPS Surprise27.06% Sales Q/Q- EarningsNov 05 BMO Avg Volume1.43M Price48.68
SMA20-1.65% SMA500.02% SMA200-12.18% Trades Volume1,673,509 Change-2.33%
Date Action Analyst Rating Change Price Target Change
Aug-06-24Reiterated Needham Buy $88 → $84
Aug-02-24Initiated Rodman & Renshaw Buy $90
Jun-28-24Resumed Guggenheim Neutral
Feb-15-24Initiated Wolfe Research Peer Perform
Dec-11-23Downgrade TD Cowen Market Perform → Underperform $30
Oct-17-23Downgrade Cantor Fitzgerald Overweight → Neutral
Sep-27-23Initiated Mizuho Buy $82
Aug-17-23Upgrade Citigroup Neutral → Buy
May-30-23Initiated William Blair Outperform $75
Apr-13-23Initiated Cantor Fitzgerald Overweight $72
Dec-09-24 12:00PM
Dec-07-24 08:45AM
Dec-06-24 12:00PM
Dec-05-24 11:30AM
05:27AM
05:44PM Loading…
Dec-02-24 05:44PM
Nov-30-24 04:35AM
Nov-24-24 05:47AM
Nov-23-24 06:30AM
Nov-21-24 05:15PM
Nov-19-24 07:03PM
Nov-18-24 06:53AM
Nov-17-24 05:11PM
Nov-16-24 06:00AM
Nov-15-24 05:45AM
08:30AM Loading…
Nov-14-24 08:30AM
Nov-13-24 06:30AM
Nov-08-24 05:20PM
01:22PM
Nov-07-24 08:00AM
Nov-06-24 12:42PM
09:55AM
Nov-05-24 10:10AM
09:01AM
05:00AM
Nov-04-24 09:35AM
09:30AM
Nov-02-24 10:00AM
Oct-31-24 04:02AM
Oct-26-24 06:32AM
05:50PM Loading…
Oct-25-24 05:50PM
Oct-22-24 11:50AM
Oct-21-24 06:00PM
09:55AM
Oct-19-24 07:30AM
Oct-16-24 03:47PM
09:45AM
Oct-15-24 06:00PM
Oct-13-24 06:30AM
Oct-12-24 08:30AM
Oct-08-24 06:00PM
Oct-05-24 04:25AM
Oct-04-24 07:13PM
Oct-02-24 06:00PM
05:00AM
04:55AM
Sep-25-24 06:00PM
Sep-21-24 07:36AM
Sep-19-24 05:50PM
04:33AM
Sep-18-24 06:00PM
Sep-12-24 08:45AM
04:15AM
Sep-10-24 05:50PM
Sep-08-24 04:51PM
11:49AM
Sep-05-24 08:45AM
Sep-04-24 11:30AM
Sep-02-24 06:15PM
Aug-30-24 08:19PM
Aug-26-24 07:30AM
Aug-19-24 11:43AM
Aug-11-24 07:28AM
Aug-09-24 10:19AM
Aug-08-24 04:56PM
06:00AM
Aug-07-24 09:00AM
Aug-06-24 10:37AM
Aug-05-24 05:25PM
04:01PM
Aug-04-24 06:22AM
Aug-01-24 12:21PM
Jul-31-24 09:45AM
Jul-30-24 09:00AM
Jul-29-24 04:00PM
10:00AM
Jul-26-24 05:50PM
Jul-24-24 08:53AM
Jul-23-24 06:00PM
09:48AM
Jul-22-24 04:45PM
Jul-20-24 06:00AM
Jul-17-24 01:30PM
11:30AM
06:08AM
Jul-16-24 01:37PM
04:15AM
Jul-11-24 08:45AM
Jul-10-24 06:00PM
Jul-09-24 07:59AM
07:30AM
07:00AM
Jul-08-24 09:00AM
06:00AM
Jul-03-24 03:11PM
Jul-01-24 08:40PM
02:31PM
Jun-27-24 10:02PM
06:39PM
03:38PM
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kulkarni SamarthChief Executive OfficerDec 02 '24Sale55.1015,000826,564181,540Dec 04 05:35 PM
Kulkarni SamarthChief Executive OfficerNov 11 '24Sale55.6230,0001,668,678196,540Nov 13 05:35 PM
KASINGER JAMES R.General Counsel and SecretaryOct 14 '24Sale46.281,08950,39962,597Oct 15 06:00 PM
Kulkarni SamarthChief Executive OfficerOct 14 '24Sale46.284,293198,680226,540Oct 15 06:00 PM
Bruno JulianneChief Operating OfficerJun 21 '24Sale56.093,366188,7996,745Jun 24 05:35 PM
Kulkarni SamarthChief Executive OfficerApr 15 '24Option Exercise19.1219,582374,408227,704Apr 17 05:45 PM
Kulkarni SamarthChief Executive OfficerApr 15 '24Sale59.9119,5821,173,232208,122Apr 17 05:45 PM
Prasad RajuChief Financial OfficerMar 15 '24Sale72.693,524256,1606,476Mar 18 05:45 PM
Kulkarni SamarthChief Executive OfficerMar 15 '24Option Exercise19.1220,000382,400228,122Mar 18 05:45 PM
Kulkarni SamarthChief Executive OfficerMar 15 '24Sale72.4820,0001,449,628208,122Mar 18 05:45 PM
KASINGER JAMES R.General Counsel and SecretaryMar 11 '24Sale78.262,801219,20660,070Mar 12 05:45 PM
KASINGER JAMES R.General Counsel and SecretaryMar 12 '24Sale74.441,14685,30861,174Mar 12 05:45 PM
Kulkarni SamarthChief Executive OfficerMar 11 '24Sale78.269,802767,105203,705Mar 12 05:45 PM
Kulkarni SamarthChief Executive OfficerMar 12 '24Sale74.444,583341,159208,122Mar 12 05:45 PM
KASINGER JAMES R.General Counsel and SecretaryFeb 20 '24Sale79.671,913152,40957,371Feb 21 05:45 PM
Kulkarni SamarthChief Executive OfficerFeb 20 '24Sale79.676,370507,498194,257Feb 21 05:45 PM
Kulkarni SamarthChief Executive OfficerFeb 15 '24Option Exercise19.1220,000382,400207,377Feb 16 05:45 PM
Kulkarni SamarthChief Executive OfficerFeb 15 '24Sale80.3620,0001,607,177187,377Feb 16 05:45 PM
Kulkarni SamarthChief Executive OfficerJan 29 '24Option Exercise19.1250,000956,000237,377Jan 31 05:45 PM
Kulkarni SamarthChief Executive OfficerJan 29 '24Sale60.5150,0003,025,573187,377Jan 31 05:45 PM
Kulkarni SamarthChief Executive OfficerJan 16 '24Option Exercise19.1220,000382,400207,377Jan 18 05:45 PM
Kulkarni SamarthChief Executive OfficerJan 16 '24Sale62.5020,0001,250,058187,377Jan 18 05:45 PM